{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:46:19Z","timestamp":1780447579566,"version":"3.54.1"},"reference-count":10,"publisher":"Pan African Medical Journal","content-domain":{"domain":["panafrican-med-journal.com"],"crossmark-restriction":true},"short-container-title":["Pan Afr Med J"],"DOI":"10.11604\/pamj.2024.49.9.31779","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T08:08:53Z","timestamp":1725869333000},"update-policy":"https:\/\/doi.org\/10.11604\/pamj.2016.07.30.0001","source":"Crossref","is-referenced-by-count":2,"title":["Liv\u00e9do r\u00e9ticulaire post vaccin anti COVID-19: \u00e0 propos d\u2019un cas"],"prefix":"10.11604","volume":"49","author":[{"given":"Meryem","family":"Ouhaddach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Zahlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia\u00e2","family":"Essaadouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40121-020-00300-x","article-title":"Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains","volume":"9","author":"Padron-Regalado E","year":"2020","unstructured":"1. Padron-Regalado E, Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains, Infect Dis Ther, 2020;9(2):255-274","journal-title":"Infect Dis Ther"},{"issue":"10275","key":"ref2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS","year":"2021","unstructured":"2. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia, Lancet, 2021;397(10275):671-681","journal-title":"Lancet"},{"issue":"6518","key":"ref3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.abe5938","article-title":"Understanding COVID-19 vaccine efficacy","volume":"370","author":"Lipsitch M, Dean NE","year":"2020","unstructured":"3. Lipsitch M, Dean NE, Understanding COVID-19 vaccine efficacy, Science, 2020;370(6518):763-765","journal-title":"Science"},{"issue":"10279","key":"ref4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty C, Otter AD, Treibel TA, McKnight \u00c1, Altmann DM, Brooks T","year":"2021","unstructured":"4. Manisty C, Otter AD, Treibel TA, McKnight \u00c1, Altmann DM, Brooks T, Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals, Lancet, 2021;397(10279):1057-1058","journal-title":"Lancet"},{"issue":"10267","key":"ref5","first-page":"1979","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR","year":"2021","unstructured":"5. Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial, Lancet, 2021;396(10267):1979-1993","journal-title":"Lancet"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clindermatol.2021.04.001","article-title":"Cutaneous adverse effects of the available COVID-19 vaccines","volume":"39","author":"Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N","year":"2021","unstructured":"6. Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N, Cutaneous adverse effects of the available COVID-19 vaccines, Clin Dermatol, 2021;39(3):523-531","journal-title":"Clin Dermatol"},{"issue":"17","key":"ref7","first-page":"1","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination","volume":"2","author":"Pai M, Chan B, Stall NM, Grill A, Ivers N, Maltsev A","year":"2021","unstructured":"7. Pai M, Chan B, Stall NM, Grill A, Ivers N, Maltsev A, Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination, Science Table COVID-19 Advisory for Ontario, 2021;2(17):1-7","journal-title":"Science Table COVID-19 Advisory for Ontario"},{"key":"ref8","article-title":"36 - Collagen Vascular and Infectious Diseases","author":"Gutierrez J, Katan M, Elkind MSV","year":"2021","unstructured":"8. Gutierrez J, Katan M, Elkind MSV, 36 - Collagen Vascular and Infectious Diseases, Accessed on 2nd Oct, 2021;","journal-title":"Accessed on 2nd Oct"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jdcr.2020.07.014","article-title":"Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection","volume":"6","author":"Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R","year":"2020","unstructured":"9. Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R, Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection, JAAD Case Rep, 2020;6(9):871-874","journal-title":"JAAD Case Rep"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy","volume":"50","author":"Becker RC","year":"2020","unstructured":"10. Becker RC, COVID-19 update: Covid-19-associated coagulopathy, J Thromb Thrombolysis, 2020;50(1):54-67","journal-title":"J Thromb Thrombolysis"}],"container-title":["The Pan African Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/49\/9\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T12:16:04Z","timestamp":1728130564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/49\/9\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":10,"URL":"https:\/\/doi.org\/10.11604\/pamj.2024.49.9.31779","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}